[Score system--potential uses and application in the assessment of results in Colles' fractures].
BACKGROUND
Colles'fractures are the most common fractures of the human skeleton, especially in winter and in menopausal women.


OBJECTIVE
The objective of the paper was to provide an overview of the potential uses of the Gartland-Werley (G-W) scoring system, that is, of its elements (residual deformities, subjective discomfort, objective discomfort and complications) in assessing the results of the Colles' fractures treatment; as well as to determine which of these elements--and to what extent--have an impact on the final result of the scoring system and what correlations exist within the G-W scoring system itself.


METHODS
Our paper included 102 patients suffering from Colles' fractures treated non-operatively with a minimum follow-up period of one year.The Gartland-Werley scoring system was used to assess the results of the non-operative treatment.


RESULTS
The results, when applying the G-W score, were excellent in 40, good in 46, satisfactory in 14, and poor in 2 patients at the end of the assessment. The G-W score elements had the following percentages in the scoring results: residual deformities 15.38%, subjective discomfort 15.38%, objective discomfort (functional results) 43.58%, and complications 25.64%. The correlation analysis showed a statistically significant correlation of the residual deformities and the total G-W score (p < 0.01) at the level of subjective discomfort and total G-W score (p < 0.01), and between objective discomfort and total G-W score at the same level.


CONCLUSIONS
Colles'fractures, as the most common fractures in humans, require a special approach and adequate assessment of final treatment results, because inadequate treatment results in the reduction of patients'daily activities and their ability to work.
Cvetković
Voja
V
Lesić
Aleksandar
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003100:Colles' Fracture / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome